HRTX
Price
$1.58
Change
-$0.02 (-1.25%)
Updated
Dec 24 closing price
56 days until earnings call
SNDX
Price
$13.07
Change
-$0.24 (-1.80%)
Updated
Dec 24 closing price
69 days until earnings call
Ad is loading...

HRTX vs SNDX

Header iconHRTX vs SNDX Comparison
Open Charts HRTX vs SNDXBanner chart's image
Heron Therapeutics
Price$1.58
Change-$0.02 (-1.25%)
Volume$702.97K
CapitalizationN/A
Syndax Pharmaceuticals
Price$13.07
Change-$0.24 (-1.80%)
Volume$2.73M
CapitalizationN/A
HRTX vs SNDX Comparison Chart
Loading...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HRTX vs. SNDX commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRTX is a StrongBuy and SNDX is a Buy.

Ad is loading...
COMPARISON
Comparison
Dec 26, 2024
Stock price -- (HRTX: $1.58 vs. SNDX: $13.07)
Brand notoriety: HRTX and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRTX: 19% vs. SNDX: 124%
Market capitalization -- HRTX: $240.31M vs. SNDX: $1.12B
HRTX [@Biotechnology] is valued at $240.31M. SNDX’s [@Biotechnology] market capitalization is $1.12B. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRTX’s FA Score shows that 0 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • HRTX’s FA Score: 0 green, 5 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, SNDX is a better buy in the long-term than HRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRTX’s TA Score shows that 6 TA indicator(s) are bullish while SNDX’s TA Score has 4 bullish TA indicator(s).

  • HRTX’s TA Score: 6 bullish, 4 bearish.
  • SNDX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, HRTX is a better buy in the short-term than SNDX.

Price Growth

HRTX (@Biotechnology) experienced а -4.24% price change this week, while SNDX (@Biotechnology) price change was -4.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

Reported Earning Dates

HRTX is expected to report earnings on Feb 20, 2025.

SNDX is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($1.12B) has a higher market cap than HRTX($240M). HRTX YTD gains are higher at: -7.059 vs. SNDX (-39.519). HRTX has higher annual earnings (EBITDA): -19.37M vs. SNDX (-296.86M). SNDX has more cash in the bank: 406M vs. HRTX (70.9M). SNDX has less debt than HRTX: SNDX (854K) vs HRTX (178M). HRTX has higher revenues than SNDX: HRTX (138M) vs SNDX (16M).
HRTXSNDXHRTX / SNDX
Capitalization240M1.12B22%
EBITDA-19.37M-296.86M7%
Gain YTD-7.059-39.51918%
P/E RatioN/AN/A-
Revenue138M16M863%
Total Cash70.9M406M17%
Total Debt178M854K20,843%
FUNDAMENTALS RATINGS
HRTX vs SNDX: Fundamental Ratings
HRTX
SNDX
OUTLOOK RATING
1..100
9664
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
10065
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4889
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HRTX's Valuation (69) in the Biotechnology industry is in the same range as SNDX (85). This means that HRTX’s stock grew similarly to SNDX’s over the last 12 months.

SNDX's Profit vs Risk Rating (65) in the Biotechnology industry is somewhat better than the same rating for HRTX (100). This means that SNDX’s stock grew somewhat faster than HRTX’s over the last 12 months.

SNDX's SMR Rating (98) in the Biotechnology industry is in the same range as HRTX (100). This means that SNDX’s stock grew similarly to HRTX’s over the last 12 months.

HRTX's Price Growth Rating (48) in the Biotechnology industry is somewhat better than the same rating for SNDX (89). This means that HRTX’s stock grew somewhat faster than SNDX’s over the last 12 months.

SNDX's P/E Growth Rating (4) in the Biotechnology industry is significantly better than the same rating for HRTX (100). This means that SNDX’s stock grew significantly faster than HRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HRTXSNDX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 8 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
75%
View a ticker or compare two or three
Ad is loading...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MXSFX9.090.08
+0.89%
Empower Real Estate Index Instl
APHDX21.780.13
+0.60%
Artisan Global Discovery Institutional
RGICX36.090.10
+0.28%
American Funds Intl Gr and Inc R3
MERFX17.050.03
+0.18%
The Merger Fund A
VEILX12.840.02
+0.16%
VELA International A

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with GSGTF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
-1.25%
GSGTF - HRTX
45%
Loosely correlated
N/A
AMRN - HRTX
44%
Loosely correlated
+2.95%
ARDX - HRTX
40%
Loosely correlated
+1.31%
ABOS - HRTX
38%
Loosely correlated
+1.13%
AXON - HRTX
38%
Loosely correlated
+1.14%
More